- Zendrive crunches 30 billion miles of smartphone data and works with Milliman to build one of the industry’s strongest predictive models
By Sheri Lee Scott | 22 August 2017
Using data collected by Zendrive, Milliman recently studied the impact of distracted driving and other driving behaviors on collision frequency.
- Understanding VM-20 Results
By Seng-Siang Goh, William C. Hines, Michael Nam, Karen K. Rudolph, William M. Sayre, Tung Tran, David Wang | 18 August 2017
This research surveys the sources of reserve movement and volatility, surveys other reporting regimes for potential attribution approaches, conducts interviews with financial reporting actuaries regarding their use of attribution methods, and provides a demonstration of a proposed attribution approach for a case study for VM-20 valuations.
- The “Rxisk” of adjustments in 2018 ACA risk adjustment
By Alan Vandagriff, Jason Petroske, Michael T. Hunter, Michelle Klein | 18 August 2017
The Centers for Medicare and Medicaid Services (CMS) is adding a new prescription drug category classification system to the 2018 risk adjustment model, and this paper approximates the likely CMS mapping based on the publicly available information to date.
- Health plan considerations for growing direct-to-consumer genetic testing
By Barbara Culley | 17 August 2017
This white paper looks at the progression of direct-to-consumer genetic testing and the current demand and growth, discusses industry concerns, and suggests activities for health plans to consider.
- Hong Kong RBC: First Quantitative Impact Study
By Michael Daly, Paul Sinnott, Clement Bonnet, Phoenix Jiang, Scott Chow | 17 August 2017
This e-Alert provides an overview of the Hong Kong Risk-based Capital regime framework development to date and comments on some of the key issues that may have a material impact on the industry.
- Impact of VM-20 on life insurance product development: Phase 2
By Paul M. Fedchak, Jacqueline M. Keating, Karen K. Rudolph, Uri Sobel, Andrew Steenman | 14 August 2017
Phase 2 of this research report expands on the Phase 1 case studies for term and universal life with secondary guarantees (ULSG) products and includes additional case studies focused on smaller companies and the impact of reinsurance.
- Pension Funding Index August 2017
By Charles J. Clark, Zorast Wadia | 10 August 2017
In July, the funded status of the 100 largest corporate defined benefit pension plans increased by $4 billion as measured by the Milliman 100 Pension Funding Index (PFI).
- Monthly Benefit News and Developments, August/September 2017
By Milliman Employee Benefits Research Group | 10 August 2017
Monthly benefits news and developments in the United States.
- Milliman FRM Market Commentary: July 2017
By Joe Becker | 08 August 2017
Markets in July climbed higher as volatility edged lower.
- Healthcare: It’s complicated
By Hans K. Leida, Lindsy Kotecki | 08 August 2017
Actuaries have had a front-row seat as healthcare reform has unfolded and are in a unique position to help address the challenges the complex system presents.